| Database ID | Agent | Target | Cancer Type | Detail |
| DB00076 | EKB569 | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | advanced solid tumors | view |
| DB00077 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | melanoma | view |
| DB00078 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | lung cancer | view |
| DB00079 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00080 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00081 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00082 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00083 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00084 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00085 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00086 | sorafenib, erlotinib | a smallmolecule multitargeted kinase inhibitor that blocks the activation of CRAF, BRAF, cKIT, FLT3, RET, vascular endothelial growth factor receptor 2 (VEGFR2), VEGFR3 and plateletderived growth factor receptor ¦Â | non small cell lung cancer | view |
| DB00087 | sorafenib, erlotinib | a smallmolecule multitargeted kinase inhibitor that blocks the activation of CRAF, BRAF, cKIT, FLT3, RET, vascular endothelial growth factor receptor 2 (VEGFR2), VEGFR3 and plateletderived growth factor receptor ¦Â | non small cell lung cancer | view |
| DB00088 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB00089 | pazopanib | Plateletderived growth factor receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |
| DB00090 | pazopanib | Plateletderived growth factor receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |